News
-
-
PRESS RELEASE
Eurobattery Minerals becomes debt-free as the final convertible bonds are fully converted into shares
Eurobattery Minerals AB announces the conversion of convertible bonds by Fenja Capital II A/S, becoming debt-free. The milestone comes as the company advances its projects, notably the San Juan tungsten project in Spain -
PRESS RELEASE
Zentra Group plc: Unaudited interim report for the six months ended 31 December 2025
Zentra Group plc announces its unaudited interim report for the six months ended 31 December 2025, with financial and operational highlights. The company focuses on property development in the North of England -
-
PRESS RELEASE
Notification of the Greenshoe-Option and Stabilization Measures in accordance with Art. 5 (4)(b), (5) and (6) of Reg. (EU) 596/2014 and Art. 8 (f) and Art. 6 (3) Comm. Delegated Reg. (EU) 2016/1052
Gabler Group AG exercises greenshoe option and ends stabilization period after IPO. Cantor Fitzgerald Ireland Limited acted as stabilisation manager -
PRESS RELEASE
ABRIDGED, PRELIMINARY AND UNAUDITED QUARTERLY AND FULL YEAR RESULTS AND DETAILS OF MANAGEMENT CONFERENCE Call for the Fourth Quarter and Full Year Ended December 31, 2025 ("The Quarter" or "Q4 2025" and "FY 2025" Respectively)
Caledonia Mining Corporation Plc reports record financial performance in FY 2025, strong cash generation, and clear growth momentum into 2026. Unaudited results show increased revenue, profit, EBITDA, and improved balance sheet. Details include gold production, sales figures, revenue growth, gross profit, and key financial metrics -
PRESS RELEASE
Capital B confirms the acquisition of 44 BTC for EUR 2.7 million, the holding of a total of 2,888 BTC, and a BTC Yield of 0.72% YTD
Capital B announces completion of capital increase and acquisition of 44 BTC, reaching total group holdings of 2,888 BTC. BTC Yield at 0.72% YTD and 0.72% QTD -
-
-
PRESS RELEASE
Just – Evotec Biologics Enters Project Agreement with BARDA to Optimize Biomanufacturing of Antibodies Against Ebola and Related Viruses
Just - Evotec Biologics partners with BARDA to optimize biomanufacturing of antibodies against Ebola & related viruses, strengthening U.S. government response capabilities
